Jarmo Hietala

15.6k total citations · 1 hit paper
239 papers, 10.1k citations indexed

About

Jarmo Hietala is a scholar working on Cellular and Molecular Neuroscience, Psychiatry and Mental health and Cognitive Neuroscience. According to data from OpenAlex, Jarmo Hietala has authored 239 papers receiving a total of 10.1k indexed citations (citations by other indexed papers that have themselves been cited), including 117 papers in Cellular and Molecular Neuroscience, 76 papers in Psychiatry and Mental health and 55 papers in Cognitive Neuroscience. Recurrent topics in Jarmo Hietala's work include Neurotransmitter Receptor Influence on Behavior (91 papers), Schizophrenia research and treatment (62 papers) and Receptor Mechanisms and Signaling (44 papers). Jarmo Hietala is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (91 papers), Schizophrenia research and treatment (62 papers) and Receptor Mechanisms and Signaling (44 papers). Jarmo Hietala collaborates with scholars based in Finland, United States and United Kingdom. Jarmo Hietala's co-authors include Erkka Syvälahti, Kjell Någren, Tiina Pohjalainen, Juha O. Rinne, Aki Laakso, Jussi Hirvonen, Mikko Kuoppamäki, Raimo K. R. Salokangas, Jaana Kajander and Harry Vilkman and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and NeuroImage.

In The Last Decade

Jarmo Hietala

231 papers receiving 9.8k citations

Hit Papers

The A1 allele of the huma... 1998 2026 2007 2016 1998 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jarmo Hietala Finland 55 4.4k 2.8k 2.6k 1.8k 1.3k 239 10.1k
S. John Gatley United States 51 6.5k 1.5× 3.0k 1.1× 3.4k 1.3× 2.4k 1.3× 2.0k 1.6× 130 11.7k
Mark Slifstein United States 57 5.6k 1.3× 2.5k 0.9× 3.3k 1.3× 2.3k 1.2× 1.4k 1.1× 147 10.3k
Jeffrey H. Meyer Canada 50 3.5k 0.8× 1.5k 0.5× 1.8k 0.7× 1.6k 0.9× 2.1k 1.6× 153 9.9k
William G. Honer Canada 59 3.1k 0.7× 5.1k 1.8× 2.4k 0.9× 2.7k 1.5× 979 0.8× 406 14.0k
Nora D. Volkow United States 33 5.2k 1.2× 2.1k 0.7× 3.6k 1.4× 1.8k 1.0× 867 0.7× 57 9.2k
Fritz A. Henn Germany 56 5.0k 1.1× 1.8k 0.6× 2.4k 0.9× 2.6k 1.4× 913 0.7× 207 11.6k
Christopher Wong United States 52 5.3k 1.2× 2.7k 1.0× 4.5k 1.7× 1.7k 0.9× 1.2k 1.0× 91 12.2k
Masaomi Iyo Japan 60 6.8k 1.5× 2.9k 1.0× 2.8k 1.1× 4.3k 2.3× 1.8k 1.4× 405 15.3k
Alessandro Bertolino Italy 57 4.3k 1.0× 3.2k 1.1× 5.8k 2.2× 2.4k 1.3× 658 0.5× 217 13.0k
Grażyna Rajkowska United States 50 4.9k 1.1× 2.0k 0.7× 3.2k 1.2× 2.5k 1.4× 1.4k 1.1× 112 12.9k

Countries citing papers authored by Jarmo Hietala

Since Specialization
Citations

This map shows the geographic impact of Jarmo Hietala's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jarmo Hietala with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jarmo Hietala more than expected).

Fields of papers citing papers by Jarmo Hietala

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jarmo Hietala. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jarmo Hietala. The network helps show where Jarmo Hietala may publish in the future.

Co-authorship network of co-authors of Jarmo Hietala

This figure shows the co-authorship network connecting the top 25 collaborators of Jarmo Hietala. A scholar is included among the top collaborators of Jarmo Hietala based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jarmo Hietala. Jarmo Hietala is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Salokangas, Raimo K. R., et al.. (2025). Childhood adversities and long-term sleep problems: The mediating role of affective symptoms. A prospective population study. Sleep Medicine. 128. 110–116. 1 indexed citations
2.
Koponen, Marjaana, et al.. (2025). Bipolar Disorder as a Long‐Term Risk Factor for Parkinson's Disease: A Nationwide Case–Control Study. Movement Disorders. 41(3). 690–698. 1 indexed citations
3.
Saarinen, Aino, et al.. (2025). Childhood family environment and μ-opioid receptor availability in vivo in adulthood. Neuropsychopharmacology. 50(7). 1130–1135. 1 indexed citations
4.
Sun, Lihua, Jouni Tuisku, Valtteri Kaasinen, et al.. (2024). Seasonal variation in D2/3 dopamine receptor availability in the human brain. European Journal of Nuclear Medicine and Molecular Imaging. 51(11). 3284–3291. 2 indexed citations
5.
Eskelinen, Saana, Tiina From, Heikki Laurikainen, et al.. (2024). Psychosis metabolic risk calculator ( PsyMetRiC ) in early psychosis: External validation study in Finland. Acta Psychiatrica Scandinavica. 151(1). 56–68. 1 indexed citations
6.
Taipale, Heidi, Antti Tanskanen, Terhi Kurko, et al.. (2024). Characteristics of high-dose benzodiazepine use: nationwide cohort study on new benzodiazepine users with 5-year follow-up. BJPsych Open. 10(5). e158–e158. 1 indexed citations
7.
Saarinen, Aino, Jarmo Hietala, Leo‐Pekka Lyytikäinen, et al.. (2023). Polygenic risk for schizophrenia predicting social trajectories in a general population sample. Psychological Medicine. 54(8). 1589–1597. 3 indexed citations
8.
Saarinen, Aino, Saara Marttila, Pashupati P. Mishra, et al.. (2023). Polygenic risk for schizophrenia, social dispositions, and pace of epigenetic aging: Results from the Young Finns Study. Aging Cell. 23(3). e14052–e14052. 2 indexed citations
9.
Lindgren, Maija, Sebastian Therman, Tiina From, et al.. (2022). Extrapyramidal symptoms predict cognitive performance after first-episode psychosis. Schizophrenia. 8(1). 64–64. 2 indexed citations
10.
Torniainen‐Holm, Minna, Markku Lähteenvuo, Jarmo Hietala, et al.. (2022). Substance Use and Sleep Problems in Patients With Psychotic Disorders. Schizophrenia Bulletin Open. 4(1). sgac073–sgac073. 1 indexed citations
11.
Lamichhane, Santosh, Alex M. Dickens, Partho Sen, et al.. (2020). Association Between Circulating Lipids and Future Weight Gain in Individuals With an At-Risk Mental State and in First-Episode Psychosis. Schizophrenia Bulletin. 47(1). 160–169. 8 indexed citations
12.
Kantonen, Tatu, Tomi Karjalainen, Janne Isojärvi, et al.. (2020). Interindividual variability and lateralization of μ-opioid receptors in the human brain. NeuroImage. 217. 116922–116922. 66 indexed citations
13.
Tuominen, Lauri, Jouko Miettunen, Dara M. Cannon, et al.. (2017). Neuroticism Associates with Cerebral in Vivo Serotonin Transporter Binding Differently in Males and Females. The International Journal of Neuropsychopharmacology. 20(12). 963–970. 15 indexed citations
14.
Kronström, Kim, Jouko K. Salminen, Jarmo Hietala, et al.. (2010). Personality traits and recovery from major depressive disorder. Nordic Journal of Psychiatry. 65(1). 52–57. 8 indexed citations
15.
Hirvonen, Jussi, Hasse Karlsson, Jaana Kajander, et al.. (2007). Decreased brain serotonin 5-HT1A receptor availability in medication-naive patients with major depressive disorder: an in-vivo imaging study using PET and [carbonyl-11C]WAY-100635. The International Journal of Neuropsychopharmacology. 11(4). 465–76. 129 indexed citations
16.
Tiihonen, Jari, Anna Keski‐Rahkonen, Jaana Kajander, et al.. (2004). Brain serotonin 1A receptor binding in bulimia nervosa. Biological Psychiatry. 55(8). 871–873. 57 indexed citations
17.
Farde, Lars, Per Karlsson, Jarmo Hietala, et al.. (1997). A PET-study of [ 11 C]FLB 457 binding to extrastriatal D 2 -dopamine receptors in healthy subjects and antipsychotic drug-treated patients. Psychopharmacology. 133(4). 396–404. 154 indexed citations
18.
Kuoppamäki, Mikko, Esa-Pekka Pälvimäki, Jarmo Hietala, & Erkka Syvälahti. (1995). Differential Regulation of Rat 5-HT2A and 5-HT2C Receptors after Chronic Treatment with Clozapine, Chlorpromazine and Three Putative Atypical Antipsychotic Drugs. Neuropsychopharmacology. 13(2). 139–150. 16 indexed citations
19.
Syvälahti, Erkka, Tiina Pohjalainen, Esa R. Korpi, et al.. (1994). Dopamine D2 Receptor Gene Expression in Rat Lines Selected for Differences in Voluntary Alcohol Consumption. Alcoholism Clinical and Experimental Research. 18(4). 1029–1031. 25 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026